Education Archives | Page 3 of 10

March212020November252024

A MEDICAL WORKER DESCRIBES TERRIFYING LUNG FAILURE FROM COVID-19 — EVEN IN HIS YOUNG PATIENTS

“It first struck me how different it was when I saw my first coronavirus patient go bad. I was like, Holy shit, this is not the flu. Watching this relatively young guy, gasping for air, pink frothy secretions coming out…

March202020November252024

U.S. MILITARY AND THE DOMESTIC CORONAVIRUS RESPONSE: KEY QUESTIONS

By Josh Michaud and Kellie Moss The domestic response to coronavirus in the U.S. is rapidly expanding. At this point, every U.S. state and territory has declared an emergency, and President Trump has declared the pandemic to represent…

March202020November252024

IVC JOINS VS IN DELAY OF CONFERENCE UNTIL JULY

By Larry Storer The International Vein Conference scheduled for April 30-May 2 in Miami Beach, Florida, has been delayed until July, Chairman Jose I. Almeida said March 20. At the time it was either to be July 9-11…

March142020November252024

CORONAVIRUS IS UNLIKE ANYTHING IN OUR LIFETIME, AND WE HAVE TO STOP COMPARING IT TO THE FLU

EDITOR’s NOTE: Longtime health reporter Charles Ornstein says that comparing the novel coronavirus to the flu is dangerously inaccurate. Not one public health expert he trusts has called that comparison valid. Here’s why. by Charles Ornstein Is the…

March142020November252024

ABOUT 4 IN 10 ADULTS IN THE U.S. ARE AT GREATER RISK OF DEVELOPING SERIOUS ILLNESS IF INFECTED WITH CORONAVIRUS

Based on current understanding of risk, forty-one percent of adults ages 18 and older in the U.S. have a higher risk of developing more serious illness if they become infected with the virus that causes COVID-19, because they are…

March112020November252024

THROMBOLEX INC. BASHIR ENDOVASCULAR CATHETER FIH TRIAL RESULTS REPORTED AT AVF MEETING

Thrombolex Inc., a medical device company focused on the design, development and manufacture of endovascular therapies for the treatment of arterial and venous thromboembolic disorders, has announced that its First-In-Human (FIH) trial confirms the early safety and feasibility…